OraSure Technologies, Inc. provided financial guidance for the fourth quarter 2023. For the period, the Company is guiding revenue of $71 to $76 million, which includes core revenue of $33 to $35 million and InteliSwab® revenue of $38 to $41 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.26 USD | +0.95% |
|
-3.18% | -48.05% |
24/06 | OraSure Technologies, Inc.(NasdaqGS:OSUR) dropped from S&P 600 Health Care | CI |
24/06 | OraSure Technologies, Inc.(NasdaqGS:OSUR) dropped from S&P 1000 | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-48.05% | 32Cr | |
-5.60% | 18TCr | |
-4.45% | 10TCr | |
-4.15% | 6.75TCr | |
-8.63% | 4.51TCr | |
+9.70% | 4.44TCr | |
+5.36% | 4.07TCr | |
+15.22% | 2.98TCr | |
+10.26% | 2.45TCr | |
-6.46% | 2.4TCr |
- Stock Market
- Equities
- OSUR Stock
- News OraSure Technologies, Inc.
- OraSure Technologies, Inc. Provides Financial Guidance for the Fourth Quarter 2023